TITLE

For Type 2 Patients Requiring Basal Insulin Initiation, Insulin Detemir Offers the Flexibility of Once-Daily Dosing in the Morning or Evening: 3-Month Results from PREDICTIVEâ„¢

AUTHOR(S)
Gallwitz, Baptist; Trippe, Bruce; Zhang, Kezhou; Lüddeke, Hansjoachim
PUB. DATE
June 2007
SOURCE
Diabetes;Jun2007 Supplement 1, Vol. 56, pA146
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the findings of the PREDICTIVE study which assessed the efficacy of insulin detemir initiation on type 2 diabetic patients in the European cohort. The subjects were switched from oral antidiabetic drugs (OADs) alone to once-daily insulin detemir ± OADs treatment. The groups which were divided based on taking the medication in the morning or in the evening showed improvements in glycemic control. There was no increased risk of hypoglycemia or weight gain found.
ACCESSION #
25820862

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics